SCHEMBL7791342

SCHEMBL7791342

C=C(C(=O)c1ccccn1)c1ccc(C(=O)NC(C=O)CCC)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ TAS1R3 Q7RTX0 2/20 0.39
▸ TAS1R1 Q7RTX1 2/20 0.39
▸ KMT2A Q03164 6/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ CES1 P23141 2/20 0.38
▸ CES2 O00748 1/20 0.38
▸ TLR7 Q9NYK1 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ PKM P14618 1/20 0.38
▸ CDK5 Q00535 1/20 0.38
▸ PAX8 Q06710 1/20 0.38
▸ CDK5R1 Q15078 1/20 0.38
▸ MAPT P10636 3/20 0.38
▸ GAA P10253 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7787777 0.85 CAPN1 (0.49) KMT2AMAPK1
SCHEMBL27656629 0.77 RAB9A (0.54) NPC1RAB9ATAS1R3TAS1R1KMT2A
SCHEMBL7466235 0.71 PSMB5 (0.51) NPC1RAB9AKMT2AMEN1TLR7
SCHEMBL10892392 0.71 CES2 (0.64) NPC1RAB9AKMT2ACES1CES2
SCHEMBL27676562 0.70 HDAC3 (0.53) NPC1RAB9ATAS1R3TAS1R1KMT2A
SCHEMBL13821939 0.69 PTPN1 (0.57) NPC1RAB9AKMT2AMEN1SMN1; SMN2
Hydrochloric Acid SCHEMBL7787786 0.68 CAPN1 (0.50) NPC1RAB9ASMN1; SMN2MAPTGAA
SCHEMBL7377431 0.67 CAPN1 (0.48) NPC1RAB9ATAS1R3TAS1R1KMT2A
SCHEMBL29351366 0.67 CASP3 (0.40) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL24862890 0.66 CAPN1 (0.56) KMT2ASMN1; SMN2MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251917-B1 Benzamidoaldehydes and their use as cysteine protease inhibitors BASF AKTIENGESELLSCHAFT (DE) 2001-06-26 — — US disclosed
Send feedback